Independent Medical Education from COR2ED developed by GI NURSES CONNECT, experts in GI & LIVER (HCC) oncology nursing https://xitter.cf/t.co/02uJQ7QU3p

Joined March 2019
GI NURSES CONNECT powered by COR2ED retweeted
Check out our Collaborators at COR2ED and this EXPERT insights from #ESMO26 GI oncologists Dr Lizzy Smyth, Dr Yelena Janjigian and Assoc. Prof. Gerald Prager join COR2ED at ESMO 2026 to provide their instant reactions on new data presented at the meeting. While Drs Smyth and Janjigian discuss gastric/GEJ cancer developments, Dr Prager will be focusing on colorectal and pancreatic cancer. @LizzySmyth1, @YJanjigianMD cor2ed.com/esmo-2026/gastric…
16
16
661
GI NURSES CONNECT powered by COR2ED retweeted
🎙️ ESMO 2026: Expert insights in NSCLC Our Collaborators at @COR2EDMedEd met with medical oncologist Dr Louise Lim at ESMO 2026 , to discuss the latest non-small cell lung cancer (NSCLC) data and what it could mean for clinical practice. 👉 cor2ed.com/highlights-from-e… 🔬 Key studies in focus: ▪️ KRAS G12C: KRAScendo 1 (LBA5) ▪️ EGFR-mutated, MET-driven NSCLC: SAFFRON (LBA6) ▪️ First-line PD-L1-negative NSCLC: OptiTROP-Lung06 (LBA66) ▪️ EGFR-mutated NSCLC post-TKI: OptiTROP-Lung04 (LBA67) Join us for expert perspectives on these emerging data and their potential implications for treatment decisions.📍 Recorded at ESMO 2026 #ESMO26 #LungCancer
17
18
931
GI NURSES CONNECT powered by COR2ED retweeted
🎥 #ESMO26 highlights from our collaborators @COR2EDMedEd Visit them at the main exhibition hall to learn more Watch Here👉 buff.ly/HBEGYqU Leading experts give quick takes on the key data, ~3 min per tumour type: 🔹 Gastric/GEJ: Smyth & Janjigian 🔹 CRC & pancreatic: Prager 🔹 HCC: Chon & Rimassa 🔹 NSCLC: Newsom-Davis & Lim 🔹 Breast: Jhaveri 🔹 GU: Iacovelli @YJanjigianMD, @tnewsomdavis, @LorenzaRimassa, @jhaveri_komal, @DrIacovelli @COR2EDMedEd
15
17
847
GI NURSES CONNECT powered by COR2ED retweeted
Drs @jhaveri_komal and @DrIacovelli are joining our collaborators at COR2ED at ESMO 2026 to share their thoughts on the latest data presented at the meeting. Dr Jhaveri will provide insights on #BreastCancer 🇺🇸 data, while Dr Iacovelli 🇮🇹 will review developments in #ProstateCancer and #BladderCancer 👉 Explore the coverage cor2ed.com/highlights-from-e…
17
24
984
GI NURSES CONNECT powered by COR2ED retweeted
📢 #ESMO26 is here; keep a look out for our conference update! In this video, Dr @tnewsomdavis, who will be sharing an update on HER2-directed NSCLC, introduces the medical experts who will be joining us at ESMO ➡️Drs @LizzySmyth1 & @YJanjigianMD: #Gastric/GEJ cancer ➡️ Assoc. Prof. Gerald Prager: #CRC & #PanCan ➡️ Prof. Hong Jae Chon & Assoc. Prof. Lorenza Rimassa: #HCC / #LiverCancer ➡️ Dr Louise Lim: #NSCLC ➡️ Dr @jhaveri_komal: #BreastCancer ➡️ Dr @DrIacovelli: #ProstateCancer & #BladderCancer What will new data mean for clinical practice? 🎬 Keep checking back to see the videos as soon as they’re released to find out: cor2ed.com/n-connect/program… Gastric/GEJ cancer update supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. HCC and HER2-directed NSCLC updates are supported by Independent Educational Grants from BeOne and Bayer, respectively. All other updates supported by COR2ED All content is intended for HCPs only #MedEd #OncTwitter #MedTwitter #pcsm #lcsm
8
8
561
GI NURSES CONNECT powered by COR2ED retweeted
📣 Update from #ASCO26! Renowned experts share their views on new data emerging from the @ASCO Annual Meeting 👉 𝘏𝘌𝘙2-mutant NSCLC: Dr @herbloong & Dr @ipreeshagul data from SOHO-01, PRO data from Beamion LUNG-1, and more ~Endorsed by @WarOnCancer, @BiomarkerCo, @Exon20Group & @isliquidbiopsy (📺Video in this post! Slides also available: cor2ed.com/n-connect/program…) 👉 #NSCLC: Prof. @MarkSocinski reviews #LungCancer data from #LIBRETTO-432, WU-KONG28 & #HARMONi-6 ~Endorsed by International Cancer Advocacy Network, Biomarker Collaborative, Exon20 Group & International Society of Liquid Biopsy 👉 #ProstateCancer: Prof. Evan Yu reviews data from #PROTEUS & #TALAPRO-3 ~Endorsed by International Cancer Advocacy Network 👉 #ColorectalCancer, #PancreaticCancer & #LiverCancer: Prof. @HPrenen reviews data from #RASolute 302, #BREAKWATER & #EMERALD-3 ~Endorsed by International Cancer Advocacy Network & @dice_europe 👉 #BreastCancer: Dr @PtarantinoMD reviews data from #ASCENT-03, ASCENT-04, #TROPION-Breast02, #SERENA-6, #VIKTORIA-1, & #OPTIMA ~Endorsed by International Cancer Advocacy Network How will these data impact clinical practice? Watch the videos to find out! ▶️ cor2ed.com/n-connect/program… 𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED. #MedEd #OncTwitter #MedTwitter #Oncology
8
12
862
GI NURSES CONNECT powered by COR2ED retweeted
Lung cancer 🫁 update from #ASCO26 👉 buff.ly/9P3rYdv Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski. #LungCancer #NSCLC #SCLC @herbloong @ipreeshagul
16
2
19
2,581
GI NURSES CONNECT powered by COR2ED retweeted
GI and hepatobiliary cancer update from ASCO 2026 Medical oncologist Prof. Hans Prenen joins @COR2EDMedEd in Chicago to share his expert insights on the latest data in colorectal, pancreatic, and liver cancers presented at ASCO 2026. How will late-breaking data impact clinical practice? Watch his video update to find out. buff.ly/dSEZYZp
14
17
1,540
GI NURSES CONNECT powered by COR2ED retweeted
Breast Cancer Update from ASCO 2026 : Watch Dr @PTarantinoMD joins @COR2EDMedEd in Chicago to share his views on the latest breast cancer data emerging from ASCO 2026. How will new developments impact clinical practice? Watch his update to find out! buff.ly/iLLs16U
1
17
19
1,530
GI NURSES CONNECT powered by COR2ED retweeted
Dear Colleagues at #ASCO26 Get expert insights on new #ProstateCancer data emerging from ASCO 2026. Prof. Evan Yu joins @COR2EDMedEd live in Chicago to share his views on how new trial data presented at the meeting could impact the clinical management of patients with prostate cancer. Watch his conference update now. Watch here👉 cor2ed.com/asco-2026/prostat…
13
15
782
📣#GICancer highlights from #ASCO26! Prof. @HPrenen shares his expert insights on key #ColorectalCancer, #PancreaticCancer & #LiverCancer #trialdata from #EMERALD-3, #BREAKWATER & #RASolute 302 How will these data impact clinical practice? Watch his video to find out! 🤝 Programme endorsed by @WarOnCancer 📺See more updates from @ASCO in 𝘏𝘌𝘙2-mutant #NSCLC, #lungcancer, #ProstateCancer & #BreastCancer >> cor2ed.com/n-connect/program… This educational programme is supported by COR2ED #MedEd #HCC #CRCSM #CRC #CancerNurses
2
101
GI NURSES CONNECT powered by COR2ED retweeted
Lung cancer 🫁 update from #ASCO26 👉 buff.ly/aQLvoj5 Renowned lung cancer experts join our collaborators at @COR2EDMedEd at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski. #LungCancer #NSCLC #SCLC @herbloong @ipreeshagul
13
1
17
3,136
GI NURSES CONNECT powered by COR2ED retweeted
📢 #ASCO26 is nearly here, keep a look out for our conference update! In this video, Dr @ipreeshagul introduces the medical experts who will be joining us at ASCO ➡️Dr @herbloong: 𝘏𝘌𝘙2-mutant NSCLC (along with Dr Preeshagul) ➡️Prof. @MarkSocinski: #NSCLC / #LungCancer ➡️Prof. Evan Yu: #ProstateCancer ➡️Prof. @HPrenen: #GIcancer: #HCC, #LiverCancer, #CRC, #PanCan ➡️ Dr @PTarantinoMD: #BreastCancer 🎬 Keep checking back to see the videos as soon as they’re released: cor2ed.com/n-connect/program… 𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED #MedEd #OncTwitter #OncMedEd
11
14
1,365
May is #OncologyNursingMonth 🩺 We want to recognise #cancernurses around the world, working tirelessly to provide the best care for their patients Thank you for all you do! 💐 From @COR2EDMedED, @GUNURSESCONNECT and GI NURSES CONNECT #IND26 #OncologyNursing
21
Useful insights on trial data, safety and real-world considerations for peri-operative immunotherapy in gastric and GEJ cancer. #MedEd
Get expert insights on the peri-operative use of immunotherapy in gastric and GEJ cancer Explore - the current treatment landscape - latest trial data - clinical impact - safety considerations and more! 📺 From Assoc. Prof. Sam Klempner (@KlempnerSam) Endorsed by @WarOnCancer, @StoCANcer & Esophageal Cancer Action Network Supported by an Independent Educational Grant from AstraZeneca US
37
LEVIATHAN data indicate lenvatinib may offer greater second-line efficacy than sorafenib after atezolizumab plus bevacizumab in unresectable HCC, even in patients with primary resistance to immunotherapy.
Get expert insights on the LEVIATHAN publication >> Evaluating lenvatinib versus sorafenib as 2nd line treatment post atezolizumab plus bevacizumab for #HCC 📺 Prof. David Pinato (@DJPinato) discusses key findings & implications for practice View/download the infographic: cor2ed.com/hcc-connect/progr… 🤝 Programme endorsed by @EuropeLiver, @BlueFaeryLiver, @GlobalLiver & @ESDO_tweets This programme is supported by an independent educational grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content. #MedEd #HCC
65
We are proud to share that more than 50,000 HCPs around the world follow @COR2EDMedEd's programmes to stay up to date with the latest science, and provide their patients with the best possible care 🎉 ~ GI NURSES CONNECT is an initiative of COR2ED ~ 👏 Over 25k HCPs subscribe to the COR2ED YouTube channel to see educational videos as soon as they're released 👏 More than 25k followers stay up to date with #MedEd on the COR2ED social media channels on X, LinkedIn, Instagram, and BlueSky Are you part of our community yet? 🎓 Follow us for engaging videos, podcasts, publications, micro learnings, and more! Our programmes are developed by renowned medical experts and endorsed by Medical Societies & Patient Advocacy Groups ✅ Come and follow us on YouTube! youtube.com/@cor2edthehearto… #medicaleducation #MedTwitter #OncTwitter #GITwitter
104
GI NURSES CONNECT powered by COR2ED retweeted
🚨 New on-demand resources! 🚨 Expert insights from the latest gastric and gastroesophageal cancer data from ESMO 2025 📺 Newly-released video & slides from a virtual Experts Knowledge Share Meeting Chair: Dr @LizzySmyth1 (UK) Co-Chairs: Prof. Aziz Zaanan (France) & Prof. Markus Moehler (Germany) The faculty shares insights for clinical practice & discusses data from key clinical trials: ✔️ FORTITUDE-101 ✔️ INTEGRATE IIb ✔️ MATTERHORN ✔️ PHERFLOT ✔️ SKYSCRAPER-07 ✔️ LEAP-014 Get the slides: cor2ed.com/gi-connect/progra… 🤝 This programme is endorsed by @ESDO_tweets, @dice_europe & @WarOnCancer Supported by an Independent Educational Grant from Amgen #MedEd #MedTwitter #ESMO25
1
2
123
‘Peri-operative use of immunotherapy in gastric and GEJ cancer’ A new #MedEd video from Assoc. Prof. Sam Klempner📺 Get expert insights on the current treatment landscape, latest trial data, clinical impact, safety considerations, and more 🤝Endorsed by @WarOnCancer & Esophageal Cancer Action Network 🔗 View the slides: cor2ed.com/gi-connect/progra… Supported by an Independent Educational Grant from AstraZeneca US #RN #OncologyNursing
29
Gastric/gastroesophageal cancer data from #ESMO 2025: Experts Knowledge Share from @giconnectInfo! 🗓️ 19th November ⏰ 17:00 - 18:15 CET / 11:00 - 12:15 EST 🔗 Register now to secure your place! engage.cor2ed.com/events/esm… Join your peers in a post-ESMO interactive webinar to explore new data and the potential implications for clinical practice The panel will discuss what’s new for - targeted therapy & IO - the peri-operative space - esophageal squamous cell carcinoma (ESCC) 🗣️ PLUS: Q&A between speakers + attendees Don’t miss it! 🤝Endorsed by: @dice_europe This independent programme is supported by an educational grant from Amgen #ESMO25 #MedEd #GIcancer #gastriccancer #ESMO2025 🎬
35